Search

Bruce McHarrie

Bruce McHarrie has been in the biotechnology industry for over 15 years. Mr McHarrie joined the Institute in 1999 after returning to Perth from the United Kingdom where he was Assistant Director in the Bioscience Unit at Rothschild Asset Management. The Bioscience Unit focused on investing in biotechnology and healthcare companies from the early start-up stage through to the publicly listed stage. In this capacity Mr McHarrie was invited to join the board of a number of United Kingdom based biotechnology companies. Prior to joining Rothschild Asset Management, Mr McHarrie was with Coopers and Lybrand in London servicing a client base primarily in the financial services industry.
Bio last updated 20 Apr 2019

Article Timeline

Access to our data for Bruce McHarrie is only available to paid subscribers with access.

The search engine is Western Australia's most accurate and comprehensive business listings and searchable database.

Bruce McHarrie is linked to 3 organisations which are included in 2 lists - Business News 30 and Public Companies - Industrial.

To see the data you will need to .

Total Shareholder Return as at 29/03/19

1 year TSR5 year TSR
469thAgrimin-30%51%
699thUltima United-61%-13%
734thStargroup-67%-27%
793rdAusCann Group Holdings-77%45%
814thSprintex-81%-51%
729 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Roles

2016
Non-Executive Director
Year started and most recent title

Revenue

176th↑AusCann Group Holdings$54k
180th↓Stargroup$17k
181st↑Agrimin$15k
183rd↑Ultima United$4k
184th↓Sprintex$1k
201 listed industrial companies ranked by revenue.
Source: Morningstar

BNiQ Disclaimer